Can MRI Replace Repeat Biopsy in Men WIth Multifocal High Grade Prostatic Intraepithelial Neoplasia or Atypical Small Acinar Proliferation?

Document Type

Conference Proceeding

Publication Date

4-2023

Publication Title

Journal of Urology

Abstract

INTRODUCTION AND OBJECTIVE: High-grade prostatic intraepithelial neoplasia (HGPIN) and atypical small acinar proliferation (ASAP) are associated with an increased risk of clinically significant prostate cancer (CaP) on subsequent prostate biopsy. We investigated the association of multiparametric MRI (mpMRI) findings in men with a previous diagnosis of HGPIN or ASAP with findings on repeat biopsy. METHODS: We retrospectively reviewed patients with multi-focal HGPIN or ASAP undergoing a repeat biopsy in the Michigan Urological Surgery Improvement Collaborative (MUSIC) registry. We compared the proportion of men with a benign biopsy, GG1, and ≥GG2 CaP on repeat biopsy within 24 months of the initial biopsy with HGPIN/ASAP. Men were placed into three groups: 1) without a mpMRI, 2) with a mpMRI demonstrating a PIRADS 1-3 lesion, 4) and PIRADS 4-5 lesion. Men with a mpMRI performed before or after the initial biopsy that demonstrated HGPIN/ASAP were analyzed separately. RESULTS: There were 219 men in the MUSIC registry with a diagnosis of HGPIN or ASAP on their initial biopsy that underwent a repeat biopsy, of which 86 had a mpMRI before (n=12) or after (n=74)the initial biopsy. Among men with a mpMRI after the initial biopsy (Figure 1), we noted that a lower proportion of men with PIRADS 1-3 lesions had GG1 (15%) or ≥GG2 (3.0%) CaP and a higher proportion had benign biopsies (82%) compared with men without a mpMRI (19%,12%, and 70%, respectively, p=0.237). Men with a PIRADS 4-5 lesion after the initial biopsy had a higher proportion of ≥GG2 (56%) and GG1(17%) CaP and a lower proportion of benign biopsies (27%) on repeatbiopsy compared with men without a mpMRI (19%, 12%, and 70%,respectively, p

Volume

209

Issue

S4

First Page

e614

Comments

American Urological Association Annual Meeting, April 28 - May 1, 2023, Chicago, IL

DOI

10.1097/JU.0000000000003290.09

Link to Full Text

Share

COinS